MA28030A1 - Procede de purification - Google Patents

Procede de purification

Info

Publication number
MA28030A1
MA28030A1 MA28862A MA28862A MA28030A1 MA 28030 A1 MA28030 A1 MA 28030A1 MA 28862 A MA28862 A MA 28862A MA 28862 A MA28862 A MA 28862A MA 28030 A1 MA28030 A1 MA 28030A1
Authority
MA
Morocco
Prior art keywords
purification process
distillation
acid addition
addition salt
terbinafine
Prior art date
Application number
MA28862A
Other languages
English (en)
Inventor
Ulrich Beutler
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA28030(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA28030A1 publication Critical patent/MA28030A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La présente invention concerne un procédé de purification pour préparer de la terbinafine pharmaceutique d'allylamine de formule (I), sous la forme d'une base libre ou d'un sel d'addition d'acide, par distillation d'une base de terbinafine brute, de préférence par distillation à passage court, par exemple à une température supérieure à 100°C et une pression réduite, par ex. 0,2 mbar, puis récupération du produit purifié sous forme de base libre ou de sel d'addition d'acide.
MA28862A 2003-08-29 2006-03-08 Procede de purification MA28030A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0320312.2A GB0320312D0 (en) 2003-08-29 2003-08-29 Purification process

Publications (1)

Publication Number Publication Date
MA28030A1 true MA28030A1 (fr) 2006-07-03

Family

ID=28686596

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28862A MA28030A1 (fr) 2003-08-29 2006-03-08 Procede de purification

Country Status (25)

Country Link
US (2) US20060076227A1 (fr)
EP (1) EP1694631A2 (fr)
JP (1) JP5208416B2 (fr)
KR (2) KR101233024B1 (fr)
CN (1) CN100491334C (fr)
AR (1) AR045506A1 (fr)
AU (1) AU2004268051B2 (fr)
BR (1) BRPI0413896A (fr)
CA (1) CA2536498C (fr)
EC (1) ECSP066382A (fr)
GB (1) GB0320312D0 (fr)
IL (1) IL173709A (fr)
IS (1) IS8369A (fr)
MA (1) MA28030A1 (fr)
MX (1) MXPA06002348A (fr)
MY (1) MY149357A (fr)
NO (1) NO20061404L (fr)
NZ (1) NZ545445A (fr)
PE (1) PE20050873A1 (fr)
RU (1) RU2367649C2 (fr)
SG (1) SG145782A1 (fr)
TN (1) TNSN06066A1 (fr)
TW (1) TWI350829B (fr)
WO (1) WO2005021483A2 (fr)
ZA (1) ZA200601264B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
EP1900378A1 (fr) * 2006-08-31 2008-03-19 Novartis AG Compositions pharmaceutiques pour le traitment d'infections fongiques
WO2010027468A1 (fr) 2008-09-05 2010-03-11 Travanti Pharma Inc. Conditionnement pour délivrance de médicaments ionophorétiques

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862103D1 (en) * 1977-08-19 1982-11-18 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
ATE10272T1 (de) 1979-08-22 1984-11-15 Sandoz Ag Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
CS232849B1 (cs) * 1983-05-04 1985-02-14 Ladislav Kalvoda Způsob přípravy honjugavaných eninů
RU2005717C1 (ru) * 1989-02-17 1994-01-15 Такеда кемикал-индастриз Лтд Способ получения производных аралкиламинов или их кислотно-аддитивных солей
CH678527A5 (en) 1989-06-22 1991-09-30 Sandoz Ag Trans(E)-N-(1-naphthyl:methyl)-heptenyl-amine prepn. - by simultaneously converting crude mixt. contg. cis and trans isomers to salt and precipitating trans isomer
JP3116364B2 (ja) 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
SK286804B6 (sk) 1999-10-22 2009-05-07 Richter Gedeon Vegy�Szeti Gy�R Rt. Spôsob prípravy substituovaného derivátu alylamínu a jeho solí
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
ITMI20010421A1 (it) 2001-03-01 2002-09-02 Ausimont Spa Membrane porose semipermeabili di fluoropolimeri semicristallini
ITMI20010430A1 (it) * 2001-03-02 2002-09-02 Dinamite Dipharma S P A In For Metodo per la sintesi di terbinafina
KR100459275B1 (ko) 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
ITMI20022534A1 (it) * 2002-11-29 2004-05-30 Dinamite Dipharma S P A Procedimento per la preparazione di terbinafina mediante l'uso di platino come catalizzatore.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof

Also Published As

Publication number Publication date
MY149357A (en) 2013-08-30
TNSN06066A1 (en) 2007-10-03
MXPA06002348A (es) 2006-05-22
CA2536498C (fr) 2012-10-09
IL173709A0 (en) 2006-07-05
US20060076227A1 (en) 2006-04-13
TW200523231A (en) 2005-07-16
WO2005021483A3 (fr) 2005-05-12
RU2006109640A (ru) 2007-10-10
ZA200601264B (en) 2007-06-27
US7985323B2 (en) 2011-07-26
TWI350829B (en) 2011-10-21
CA2536498A1 (fr) 2005-03-10
AU2004268051B2 (en) 2009-03-05
BRPI0413896A (pt) 2006-10-24
US20090216047A1 (en) 2009-08-27
IS8369A (is) 2006-03-23
WO2005021483A2 (fr) 2005-03-10
SG145782A1 (en) 2008-09-29
ECSP066382A (es) 2006-09-18
IL173709A (en) 2012-02-29
EP1694631A2 (fr) 2006-08-30
CN1845895A (zh) 2006-10-11
JP2007504110A (ja) 2007-03-01
GB0320312D0 (en) 2003-10-01
AU2004268051A1 (en) 2005-03-10
NZ545445A (en) 2010-03-26
RU2367649C2 (ru) 2009-09-20
CN100491334C (zh) 2009-05-27
AR045506A1 (es) 2005-11-02
PE20050873A1 (es) 2005-11-21
NO20061404L (no) 2006-08-25
KR101233024B1 (ko) 2013-02-13
KR20060119892A (ko) 2006-11-24
KR20120054109A (ko) 2012-05-29
JP5208416B2 (ja) 2013-06-12

Similar Documents

Publication Publication Date Title
KR900000274B1 (ko) 1-(1-아릴사이클로부틸)알킬아민 유도체의 제조방법
US5296604A (en) Proline derivatives and compositions for their use as inhibitors of HIV protease
JPH04500215A (ja) Ｎ―フェニルアルキル置換α―アミノカルボキシアミド誘導体およびその製造方法
KR100266927B1 (ko) 2-((디메틸아미노)메틸)-1-(3-메톡시페닐)사이클로헥산올 및 그의 염의 정제 방법
KR101633298B1 (ko) Ｎ,ｎ-디알킬 락트아미드의 제조 방법
JPS60132935A (ja) フエニルセリン誘導体及びその製造方法
TW505624B (en) Novel process for preparing a ketimine
MA28030A1 (fr) Procede de purification
JPH04275258A (ja) 光学活性１−アリール−アルキルアミン類のラセミ化方法
CN1863761A (zh) 由可通过氨和环氧乙烷的反应获得的混合物分离三乙醇胺的方法
EP3665159A1 (fr) Procédé de conversion de mono-urée cyclique d'un composé d'éthylèneamine en composé d'éthylèneamine
MX2007010403A (es) Proceso de purificacion.
JP2002167369A (ja) 高重合性ｎ−ビニルカルボン酸アミドの製造方法
JP4467890B2 (ja) チオフェンのクロロメチル化
EP0869952B1 (fr) Derives de 5-naphtalen-1-y1-1,3-dioxanes, leur preparation et leur application en therapeutique
JPH0560817B2 (fr)
JPH0617342B2 (ja) 光学活性β−アミノアルコ−ルの製造方法
KR100881890B1 (ko) 사포그렐레이트 염산염의 제조방법
FR2470110A1 (fr) Derives de la decrapenylamine, leurs sels acides d'addition et composition pharmaceutique renfermant ces produits
JP2562689B2 (ja) ジアルキルカーボネートの精製方法
JP4402500B2 (ja) イオパミドールの精製方法
JPH0217194A (ja) 光学的活性なｄ‐２‐ｎ‐フエナセチルアミノ‐４‐メチルホスフィノ酪酸のラセミ化法
JPH0399042A (ja) Ｎ―置換アミノフェノール類の製造方法
EP1506156A1 (fr) Procede de preparation de 2-alkoxyphenoxyethanamines a partir de 2-alkoxyphenoxyethylacetamides
JPH0267237A (ja) 光学活性１，１，１−トリフルオロ−２−アルカノールの製造法